PRUFIBRY
Live / Registered — Registered (as of 02 Sept 2025)
What this means for you
Registered since 02 Sept 2025. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 79406268
- Registration number
- 7924146
- Mark type
- Stylized text
- Filed
- 12 Apr 2024
- Published for opposition
- 15 Jul 2025
- Registered
- 02 Sept 2025
- Attorney of record
- Garth M. Dahlen
Goods and services
- Class 001 — Chemicals: Biological preparations for use in industry and science, namely proteins and protein preparations derived from human blood, blood plasma, or blood serum, coagulation factors; biological preparations, namely plasma and serum preparations for cultivating cells, tissue, or organs for industrial and scientific purposes.
- Class 005 — Pharmaceuticals: Pharmaceutical, medical and veterinary preparations for hematology, for intensive care medicine, for transplantation medicine, for oncology, for influencing blood diseases, and for influencing blood coagulation; blood products, blood substitute, and blood plasma substitute for medical purposes; blood serums preparations for medical purposes, in particular those containing serum proteins and related solutions; pharmaceutical proteins and medical protein preparations made from human blood, blood plasma and blood serum for hematology, for intensive care medicine, for transplantation medicine, for oncology, for influencing blood diseases, and for influencing blood coagulation; pharmaceutical preparations in the nature of human coagulation factors for hematology, for intensive care medicine, for transplantation medicine, for the treatment of oncology, for influencing blood diseases, and for influencing blood coagulation; fibrinogen and fibrinogen made from human blood plasma, in the nature of pharmaceutical preparations for hematology, for intensive care medicine, for transplantation medicine, for the treatment of oncology, for influencing blood diseases, and for influencing blood coagulation; pharmaceutical and veterinary products for hematology, intensive care medicine, transplantation medicine, oncology, for influencing blood diseases, and for influencing blood coagulation
Owner
- Biotest AG, DE
- Biotest AG, DE
- Biotest AG, DE
Prosecution history
- 26 Mar 2026 — NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
- 19 Mar 2026 — FINAL DISPOSITION NOTICE SENT TO IB
- 19 Mar 2026 — FINAL DISPOSITION PROCESSED
- 09 Mar 2026 — NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
- 09 Mar 2026 — NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
- 02 Dec 2025 — FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
- 02 Sept 2025 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 02 Sept 2025 — REGISTERED-PRINCIPAL REGISTER
- 15 Jul 2025 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 15 Jul 2025 — PUBLISHED FOR OPPOSITION
- 09 Jul 2025 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 11 Jun 2025 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 11 Jun 2025 — EXAMINER'S AMENDMENT ENTERED
- 11 Jun 2025 — NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
- 11 Jun 2025 — EXAMINERS AMENDMENT E-MAILED